Product Reports Resources Pricing Login Book a demo
COMPANY PROFILE

Stratasan

Explore full profile

Actionable Healthcare Market Intelligence

Nashville, United StatesFounded 2010Other B2B Software
Valuation $100–250M Last recorded · 2019
Headcount <100 Current team size
Total funding $10–50M Disclosed equity funding
Unlock exact values This page shows ranges. Dealroom has the exact numbers for Stratasan and the history behind them.

About Stratasan

Stratasan operates as a specialized provider of data analytics and market intelligence for the healthcare sector, now functioning as a division of Syntellis Performance Solutions. The firm was founded in Nashville, Tennessee, in 2010 by Jason Moore and Brian Dailey. Moore, who served as CEO, brought a background in client-facing roles and prior startup experience, while Dailey, the CTO, contributed deep technical expertise from his work in web application development. Their collaboration was born from the recognition that healthcare systems needed a product-focused, customer-centric approach to strategic growth planning.

The company's business model is centered on a Software-as-a-Service (SaaS) platform that delivers actionable intelligence to its client base, which primarily consists of hospitals, healthcare systems, ancillary care centers, and payers. Stratasan generates revenue by providing subscription-based access to this proprietary software, supplemented by a professional services team known as “Spark Services.” This combination helps healthcare organizations identify growth opportunities, understand patient demographics, and monitor performance against strategic goals. Key use cases for clients include optimizing locations for new facilities, improving physician recruitment and relations, and analyzing patient referral patterns to reduce outmigration.

The core offering is a web-based software platform that aggregates and analyzes various datasets, including all-payer claims, state and Medicare data, and internal patient information. This enables strategic planners and marketing teams at healthcare facilities to move beyond raw data compilation to informed decision-making. The platform's benefits include providing insights for service line expansion, enhancing patient outreach campaigns, and negotiating more favorable reimbursement rates. A significant milestone in the company's history was its acquisition by Syntellis Performance Solutions, a deal announced in July 2022 and completed in August 2022. This transaction integrated Stratasan's market intelligence capabilities with Syntellis's broader suite of enterprise performance management solutions, aiming to offer a comprehensive platform that links operational, financial, and strategic data for healthcare providers.

Source: Dealroom company data

At a glance

Status
Acquired
Founded
2010
Headquarters
Nashville, United States
Employees
68
Open positions
None listed
Dealroom signal
59.4/100
Industry
Enterprise Software
Sector
Other B2B Software, Analytics, Cloud Computing, Data Analytics, Healthcare
Technology
Big Data
Business model
SaaS
Client focus
b2b

Funding history

4 recorded events

Company financing events and reported valuations.

Deal typeDateAmountValuationInvestorsSource
ACQUISITION✓Exit Jul 2022 $0 — Syntellis Performance Solutions | Axiom EPM ↗
EARLY VC✓Equity / VC Jul 2019 $26M $104M Frist Cressey Ventures · Fulcrum Equity Partners · Heron Capital · Bridge Bank —
Showing the latest 2 of 4 recorded eventsBook a demo for the full funding history →

Growth signals

Stratasan website traffic

Latest recorded traffic for Stratasan is 840 monthly website visits, down 23.6% over the last three months. Stratasan's team grew 0% over the past year.

Latest monthly visits840 3-month web change-23.6% 1-year team growth0%
Summary metrics are public; monthly history is available with a demoCompare with peers →

Investments and acquisitions

Capital deployed

Recent portfolio relationships for companies that also act as investors or acquirers.

Investors

7 investors on the cap table

From Dealroom's funding and investor records, grouped by the round each investor first entered.

Series A4 investors entered at this stage

  • Frist Cressey Ventures
  • Fulcrum Equity Partners
  • Heron Capital
  • Bridge Bank

Other known investors3 additional known investors

  • Syntellis Performance Solutions | Axiom EPM
  • Blue Heron Capital
  • Venture for America
Team profiled 2 named & role-tagged
Founders Hidden — book a demo/100 quality score
Key operators 1 quality Hidden — book a demo/100
Potential founders Hidden — book a demo likely future founders
Startup mafia Hidden — book a demo alumni-founded startups
Talent movements Hidden — book a demo in · Hidden — book a demo out past 12 months

Source: Dealroom Talent Intelligence.

Global footprint

Workforce and web traffic by country
Workforce by country
🇺🇸 United States · Nashville HQ
Book a demo for the full country breakdown

Market sentiment

Posts on X, past 7 days

An AI-synthesised read of the highest-engagement posts about Stratasan on X, ranked by likes and reposts, corporate channels excluded.

Reading the room on X — pulling top posts and synthesizing themes…

Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

See Stratasan’s full profile on Dealroom

Request a free trial to see the complete deal history, financials, people graph and growth signals.

Takes under a minute. Already use Dealroom? Log in.